389 related articles for article (PubMed ID: 8781336)
1. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats.
Yasuda H; Imai E; Shiota A; Fujise N; Morinaga T; Higashio K
Hepatology; 1996 Sep; 24(3):636-42. PubMed ID: 8781336
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.
Nakamura T; Sakata R; Ueno T; Sata M; Ueno H
Hepatology; 2000 Aug; 32(2):247-55. PubMed ID: 10915731
[TBL] [Abstract][Full Text] [Related]
3. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.
Baroni GS; D'Ambrosio L; Curto P; Casini A; Mancini R; Jezequel AM; Benedetti A
Hepatology; 1996 May; 23(5):1189-99. PubMed ID: 8621153
[TBL] [Abstract][Full Text] [Related]
4. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
[TBL] [Abstract][Full Text] [Related]
5. Anti-fibrotic effects of the anthocyanins isolated from the purple-fleshed sweet potato on hepatic fibrosis induced by dimethylnitrosamine administration in rats.
Choi JH; Hwang YP; Choi CY; Chung YC; Jeong HG
Food Chem Toxicol; 2010 Nov; 48(11):3137-43. PubMed ID: 20728498
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
Abe W; Ikejima K; Lang T; Okumura K; Enomoto N; Kitamura T; Takei Y; Sato N
J Hepatol; 2007 Feb; 46(2):286-94. PubMed ID: 17166617
[TBL] [Abstract][Full Text] [Related]
7. Remote delivery and expression of soluble type II TGF-beta receptor in muscle prevents hepatic fibrosis in rats.
Nakamuta M; Morizono S; Tsuruta S; Kohjima M; Kotoh K; Enjoji M
Int J Mol Med; 2005 Jul; 16(1):59-64. PubMed ID: 15942678
[TBL] [Abstract][Full Text] [Related]
8. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.
Matsuda Y; Matsumoto K; Yamada A; Ichida T; Asakura H; Komoriya Y; Nishiyama E; Nakamura T
Hepatology; 1997 Jul; 26(1):81-9. PubMed ID: 9214455
[TBL] [Abstract][Full Text] [Related]
9. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
10. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats.
Tashiro H; Fudaba Y; Itoh H; Mizunuma K; Ohdan H; Itamoto T; Asahara T
Transplantation; 2003 Sep; 76(5):761-5. PubMed ID: 14501849
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
[TBL] [Abstract][Full Text] [Related]
14. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
Rockey DC; Chung JJ
J Investig Med; 1994 Dec; 42(4):660-70. PubMed ID: 8521029
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
16. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S
Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207
[TBL] [Abstract][Full Text] [Related]
17. Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis.
Miyazaki T; Karube M; Matsuzaki Y; Ikegami T; Doy M; Tanaka N; Bouscarel B
J Hepatol; 2005 Jul; 43(1):117-25. PubMed ID: 15893842
[TBL] [Abstract][Full Text] [Related]
18. The flavonoid quercetin inhibits dimethylnitrosamine-induced liver damage in rats.
Lee ES; Lee HE; Shin JY; Yoon S; Moon JO
J Pharm Pharmacol; 2003 Aug; 55(8):1169-74. PubMed ID: 12956909
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats.
Yasuda M; Shimizu I; Shiba M; Ito S
Hepatology; 1999 Mar; 29(3):719-27. PubMed ID: 10051473
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver.
Nakatsukasa H; Evarts RP; Hsia CC; Thorgeirsson SS
Lab Invest; 1990 Aug; 63(2):171-80. PubMed ID: 2381163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
